What Is Journavx, the New Opioid-Free Painkiller from Vertex?

Category: Health

The FDA has approved a new painkiller, suzetrigine (Journavx), which effectively alleviates moderate to severe acute pain without the addiction risks associated with opioids. Developed by Vertex, suzetrigine works by blocking sodium ion channels, preventing pain signals from reaching the brain. Clinical trials showed it performs similarly to opioids but with fewer side effects. This new medication offers a crucial alternative in pain management, especially amid the ongoing opioid crisis.

Keywords: suzetrigine, painkiller, FDA approval

Source: Scientific American

Update At: 2/1/2025

Related Sources

expert comments about hMPV (human metapneumovirus) following media reports about cases in China | Science Media Centre

Experts comment on the recent cases of Human Metapneumovirus (hMPV) in China, highlighting its commonality as a respiratory virus, its symptoms, and the importance of preventive measures. They note that while hMPV can lead to severe illness in vulnerable populations, it typically causes mild cold-like symptoms. The increase in diagnoses is attributed to improved testing methods rather than a significant rise in infections.

Science Media Centre

Human Metapneumovirus: let’s all calm down first

Human metapneumovirus (HMPV) is not a new virus but has been misrepresented in media reports, causing unnecessary panic. It typically causes mild respiratory infections but can be severe in vulnerable populations. The focus on HMPV diverts attention from more pressing health issues like influenza and RSV. Responsible journalism and accurate reporting from health authorities are crucial to counter misinformation. Strengthening surveillance and supporting low-cost diagnostic tests for HMPV are essential for better public health management.

The Hindu

Viral video showing HMPV chaos at China hospital raises alarm. Is human metapneumovirus a new virus?

HMPV, or Human Metapneumovirus, is a respiratory virus that has gained attention due to a recent outbreak in China, particularly affecting children under 14. Symptoms include cough, fever, and sore throat, similar to other respiratory viruses. Although HMPV is not new, having been identified in 2001, its recent surge in cases coincides with seasonal trends. Health authorities are monitoring the situation closely, and neighboring countries are on alert for potential spread.

Economic Times

Global HMPV Tracker: Tamil Nadu Detects 2 Cases, India's Tally Rises To 5

Health experts confirm that Human Metapneumovirus (HMPV) is not a new virus, having been identified in 2001 and circulating globally. While cases have been reported in India, the majority of the population is believed to be immune. Precautionary measures are being taken, especially in West Bengal, where no cases have been detected yet. Concerns over HMPV's impact have also affected Indian markets, prompting calls for immediate action from government officials.

NDTV

HMPV Cases LIVE: Devendra Fadnavis says Metapneumovirus is ‘not a new virus’

ICMR confirmed two Human Metapneumovirus cases in Karnataka, with an additional case reported in Ahmedabad, Gujarat. Maharashtra CM Devendra Fadnavis stated that Metapneumovirus is not a new virus.

Livemint

What you need to know about HMPV as China sees rise in cases

China is monitoring a rise in human metapneumovirus (HMPV) cases, with no evidence of an unusual outbreak. HMPV, a respiratory virus, is common during winter and can cause symptoms similar to other respiratory infections. It spreads through respiratory secretions and close contact. There is no specific antiviral treatment or vaccine for HMPV, and prevention includes good hygiene practices and vaccination against other respiratory viruses.

ABC News

What is HMPV? What to know about the virus as cases tick up in China and the US

China is monitoring an increase in human metapneumovirus (HMPV) cases, though officials state the outbreak is not unusual and poses a low risk for a COVID-19-like pandemic. In the U.S., HMPV cases have also risen, with the CDC closely observing the situation. HMPV can cause respiratory illness, with symptoms similar to colds, and there is no specific treatment or vaccine available. Preventative measures include handwashing and avoiding close contact with sick individuals.

USA TODAY

Impacts to VCU Health due to weather, boil water advisory | VCU Health

VCU Health is affected by a boil water advisory due to hazardous weather conditions in Central Virginia. All elective surgeries and outpatient diagnostic tests are canceled, and several clinics are closed. Residents are advised to boil water before consumption and conserve water during this advisory.

VCU Health

First H5 Bird Flu Death Reported in United States

A person in Louisiana has died from H5N1 bird flu, marking the first death from this virus in the U.S. since 2024. The CDC reports 66 confirmed human cases of H5N1 in the U.S. since 2024, with a low risk to the general public and no person-to-person transmission identified. The CDC continues to monitor the situation and provide resources for prevention.

Santa Barbara Independent

First US Bird Flu Death Reported In Louisiana After Severe Case Of H5N1

A Louisiana resident has died from bird flu, marking the first U.S. death from the H5N1 virus. The patient, over 65 with underlying conditions, was exposed to infected wild birds and backyard poultry. The CDC assesses the public health risk as low, with no person-to-person transmission identified. The D1.1 strain of the virus was involved, which has shown concerning mutations. The CDC has recorded 66 human cases of H5 strains in the U.S. since last year, primarily among workers with infected cattle.

news9.com KWTV